Study of the efficacy, biodistribution, and safety profile of therapeutic gutless adenovirus vectors as a prelude to a phase I clinical trial for glioblastoma.
about
Adenoviral vector immunity: its implications and circumvention strategies.A novel bicistronic high-capacity gutless adenovirus vector that drives constitutive expression of herpes simplex virus type 1 thymidine kinase and tet-inducible expression of Flt3L for glioma therapeuticsMarmosets as a preclinical model for testing "off-label" use of doxycycline to turn on Flt3L expression from high-capacity adenovirus vectors.Adenoviral vector-mediated gene therapy for gliomas: coming of age.Current status of gene therapy for brain tumors.Plasmacytoid dendritic cells in the tumor microenvironment: immune targets for glioma therapeutics.New therapeutic approaches for malignant glioma: in search of the Rosetta stoneSafety profile of gutless adenovirus vectors delivered into the normal brain parenchyma: implications for a glioma phase 1 clinical trialSafety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastomaPreclinical Efficacy and Safety Profile of Allometrically Scaled Doses of Doxycycline Used to Turn "On" Therapeutic Transgene Expression from High-Capacity Adenoviral Vectors in a Glioma ModelHelper-Dependent Adenoviral Vectors.Effectiveness and preclinical safety profile of doxycycline to be used "off-label" to induce therapeutic transgene expression in a phase I clinical trial for gliomaGene therapy with helper-dependent adenoviral vectors: current advances and future perspectives.Helper-Dependent Adenoviral Vectors and Their Use for Neuroscience Applications.Sustained production of a soluble IGF-I receptor by gutless adenovirus-transduced host cells protects from tumor growth in the liver.Prolonged regulatable expression of EPO from an HSV vector using the LAP2 promoter elementDevelopment of preclinical models for immunogene therapy of brain cancer: it's not monkey business!Pancreatic transduction by helper-dependent adenoviral vectors via intraductal delivery.Self-inactivating helper virus for the production of high-capacity adenoviral vectors.Gene therapy and targeted toxins for glioma
P2860
Q33565630-7DB40E36-53FA-4EAB-8F29-3FA7374167BCQ33877450-6EBACC2F-FF95-4770-89B1-B02B65431D78Q33950709-DFD67EF9-BC73-4AFD-8C45-4851658DC1A3Q34022048-36A3EA0B-A5A6-4AFB-8C60-3A72DC3DC193Q34318157-C95BE868-1B7D-4EFA-BBE5-CD2D90F19474Q36200438-0DD2294B-9B12-4A31-94F3-5298A1F0E7D0Q36224493-66773FD1-C358-40A3-8D12-624E6037C00DQ36534329-84F0E020-E575-495D-A323-D80BCA62F05CQ36811505-4DE70C42-1E90-4863-915F-E66377E0AEEAQ37050094-FEEFF86A-10F3-4C70-9529-B72D78EAC075Q37582126-D9B44A80-DAF3-49D6-A4D2-DC26CF90985DQ37730116-485D7340-9816-446C-B507-17F503080B0BQ37945218-6AA01294-CABE-4421-9BC3-5EFACA7E5A99Q38436558-A7E63A44-C564-46AB-91C2-454A14A936ADQ39183606-C8DCC386-C6FA-4A3A-894D-28F1C2D99310Q39442049-313DB85C-D29A-4AF3-851E-5165A6BED1C1Q41922812-76AA1404-6053-42B3-8C2D-94B9CFF079F1Q42204796-9A653E7C-DD4F-46C4-B90C-AFB82224068DQ45367025-CF46CDF7-D27D-4F13-B576-75F53EA5186CQ57006162-99EDD216-A874-41B9-9D4E-D7D831EF9F25
P2860
Study of the efficacy, biodistribution, and safety profile of therapeutic gutless adenovirus vectors as a prelude to a phase I clinical trial for glioblastoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Study of the efficacy, biodist ...... inical trial for glioblastoma.
@ast
Study of the efficacy, biodist ...... inical trial for glioblastoma.
@en
Study of the efficacy, biodist ...... inical trial for glioblastoma.
@nl
type
label
Study of the efficacy, biodist ...... inical trial for glioblastoma.
@ast
Study of the efficacy, biodist ...... inical trial for glioblastoma.
@en
Study of the efficacy, biodist ...... inical trial for glioblastoma.
@nl
prefLabel
Study of the efficacy, biodist ...... inical trial for glioblastoma.
@ast
Study of the efficacy, biodist ...... inical trial for glioblastoma.
@en
Study of the efficacy, biodist ...... inical trial for glioblastoma.
@nl
P2093
P2860
P356
P1476
Study of the efficacy, biodist ...... inical trial for glioblastoma.
@en
P2093
A K M G Muhammad
C Farrokhi
J F Curtin
K Lawrence
P2860
P304
P356
10.1038/CLPT.2009.260
P407
P577
2010-02-17T00:00:00Z